Chemoinformaics analysis of 4-Hydroxy-3-methoxycinnamaldehyde
| Molecular Weight | 178.187 | nRot | 3 |
| Heavy Atom Molecular Weight | 168.107 | nRig | 8 |
| Exact Molecular Weight | 178.063 | nRing | 1 |
| Solubility: LogS | -1.919 | nHRing | 0 |
| Solubility: LogP | 1.708 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 25.7739 |
| nHD | 1 | BPOL | 12.6361 |
| QED | 0.565 |
| Synth | 2.197 |
| Natural Product Likeliness | 1.348 |
| NR-PPAR-gamma | 0.014 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.161 |
| HIA | 0.011 |
| CACO-2 | -4.585 |
| MDCK | 0.0000181 |
| BBB | 0.879 |
| PPB | 0.893365 |
| VDSS | 0.939 |
| FU | 0.0907157 |
| CYP1A2-inh | 0.876 |
| CYP1A2-sub | 0.847 |
| CYP2c19-inh | 0.105 |
| CYP2c19-sub | 0.396 |
| CYP2c9-inh | 0.067 |
| CYP2c9-sub | 0.87 |
| CYP2d6-inh | 0.023 |
| CYP2d6-sub | 0.901 |
| CYP3a4-inh | 0.028 |
| CYP3a4-sub | 0.211 |
| CL | 10.075 |
| T12 | 0.89 |
| hERG | 0.028 |
| Ames | 0.691 |
| ROA | 0.942 |
| SkinSen | 0.949 |
| Carcinogencity | 0.787 |
| EI | 0.981 |
| Respiratory | 0.953 |
| NR-Aromatase | 0.037 |
| Antiviral | No |
| Prediction | 0.859212 |